Dicot AB (XSAT:DICOT) Asset Impairment Charge : kr0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Dicot AB Asset Impairment Charge?

Dicot AB's Asset Impairment Charge for the three months ended in Dec. 2023 was kr0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00 Mil.

Dicot AB Asset Impairment Charge Historical Data

The historical data trend for Dicot AB's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB Asset Impairment Charge Chart

Dicot AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

Dicot AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Dicot AB Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Dicot AB Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Dicot AB's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Dicot AB (XSAT:DICOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (XSAT:DICOT) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

KN0:Germany

Address

Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37

Website

http://www.dicot.se

Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (XSAT:DICOT) Headlines

No Headlines